These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 18022173

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Effects of aged garlic extract (AGE) on colorectal adenomas: a double-blinded study.
    Tanaka S, Haruma K, Kunihiro M, Nagata S, Kitadai Y, Manabe N, Sumii M, Yoshihara M, Kajiyama G, Chayama K.
    Hiroshima J Med Sci; 2004 Dec; 53(3-4):39-45. PubMed ID: 15726891
    [Abstract] [Full Text] [Related]

  • 43. Peptic ulcer and bleeding events associated with rofecoxib in a 3-year colorectal adenoma chemoprevention trial.
    Lanas A, Baron JA, Sandler RS, Horgan K, Bolognese J, Oxenius B, Quan H, Watson D, Cook TJ, Schoen R, Burke C, Loftus S, Niv Y, Ridell R, Morton D, Bresalier R.
    Gastroenterology; 2007 Feb; 132(2):490-7. PubMed ID: 17258718
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Dietary and supplemental calcium and the recurrence of colorectal adenomas.
    Hyman J, Baron JA, Dain BJ, Sandler RS, Haile RW, Mandel JS, Mott LA, Greenberg ER.
    Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):291-5. PubMed ID: 9568783
    [Abstract] [Full Text] [Related]

  • 46. Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial.
    Jaszewski R, Misra S, Tobi M, Ullah N, Naumoff JA, Kucuk O, Levi E, Axelrod BN, Patel BB, Majumdar AP.
    World J Gastroenterol; 2008 Jul 28; 14(28):4492-8. PubMed ID: 18680228
    [Abstract] [Full Text] [Related]

  • 47. Three randomized long-term surveillance trials in patients with sporadic colorectal adenomas.
    Kronborg O, Jørgensen OD, Fenger C, Rasmussen M.
    Scand J Gastroenterol; 2006 Jun 28; 41(6):737-43. PubMed ID: 16716975
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. [Folic acid supplementation and colorrectal adenoma recurrence: systematic review].
    Castillo-Lancellotti C, Tur Marí JA, Uauy Dagach R.
    Nutr Hosp; 2012 Jun 28; 27(1):13-21. PubMed ID: 22566300
    [Abstract] [Full Text] [Related]

  • 50. Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial.
    Benamouzig R, Uzzan B, Deyra J, Martin A, Girard B, Little J, Chaussade S, Association pour la Prévention par l'Aspirine du Cancer Colorectal Study Group (APACC).
    Gut; 2012 Feb 28; 61(2):255-61. PubMed ID: 21890814
    [Abstract] [Full Text] [Related]

  • 51. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
    Hull MA, Sandell AC, Montgomery AA, Logan RF, Clifford GM, Rees CJ, Loadman PM, Whitham D.
    Trials; 2013 Jul 29; 14():237. PubMed ID: 23895505
    [Abstract] [Full Text] [Related]

  • 52. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.
    Flossmann E, Rothwell PM, British Doctors Aspirin Trial and the UK-TIA Aspirin Trial.
    Lancet; 2007 May 12; 369(9573):1603-13. PubMed ID: 17499602
    [Abstract] [Full Text] [Related]

  • 53. Aspirin chemoprevention in patients with increased risk for colorectal cancer: a cost-effectiveness analysis.
    DuPont AW, Arguedas MR, Wilcox CM.
    Aliment Pharmacol Ther; 2007 Aug 01; 26(3):431-41. PubMed ID: 17635378
    [Abstract] [Full Text] [Related]

  • 54. Chemoprevention of colorectal cancer: why all the confusion?
    Bresalier RS.
    Curr Opin Gastroenterol; 2008 Jan 01; 24(1):48-50. PubMed ID: 18043232
    [Abstract] [Full Text] [Related]

  • 55. The effect of aspirin in the recurrence of colorectal adenomas: a meta-analysis of randomized controlled trials.
    Gao F, Liao C, Liu L, Tan A, Cao Y, Mo Z.
    Colorectal Dis; 2009 Nov 01; 11(9):893-901. PubMed ID: 19055515
    [Abstract] [Full Text] [Related]

  • 56. Repeat-screening colonoscopy 5 years after normal baseline-screening colonoscopy in average-risk Chinese: a prospective study.
    Leung WK, Lau JY, Suen BY, Wong GL, Chow DK, Lai LH, To KF, Yim CK, Lee ES, Tsoi KK, Ng SS, Sung JJ.
    Am J Gastroenterol; 2009 Aug 01; 104(8):2028-34. PubMed ID: 19455125
    [Abstract] [Full Text] [Related]

  • 57. Folic acid and risk of prostate cancer: results from a randomized clinical trial.
    Figueiredo JC, Grau MV, Haile RW, Sandler RS, Summers RW, Bresalier RS, Burke CA, McKeown-Eyssen GE, Baron JA.
    J Natl Cancer Inst; 2009 Mar 18; 101(6):432-5. PubMed ID: 19276452
    [Abstract] [Full Text] [Related]

  • 58. Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention.
    Barry EL, Baron JA, Bhat S, Grau MV, Burke CA, Sandler RS, Ahnen DJ, Haile RW, O'Brien TG.
    J Natl Cancer Inst; 2006 Oct 18; 98(20):1494-500. PubMed ID: 17047198
    [Abstract] [Full Text] [Related]

  • 59. Determination of the minimal essential serum folate concentration for reduced risk of colorectal adenoma.
    Fujimori S, Gudis K, Takahashi Y, Kotoyori M, Tatsuguchi A, Ohaki Y, Sakamoto C.
    Clin Nutr; 2011 Oct 18; 30(5):653-8. PubMed ID: 21612847
    [Abstract] [Full Text] [Related]

  • 60. A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma.
    Wu K, Platz EA, Willett WC, Fuchs CS, Selhub J, Rosner BA, Hunter DJ, Giovannucci E.
    Am J Clin Nutr; 2009 Dec 18; 90(6):1623-31. PubMed ID: 19864409
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.